OxyVita Inc.
PrivateCompany Overview
OxyVita Inc. is a biotechnology company that develops and produces OxyVita, a zero-link polymerized hemoglobin intended to be a blood substitute.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
hemoglobin-based oxygen carrierHBOCblood substituteartificial bloodoxygen therapeuticblood transfusion alternativezero-link polymerizationpolymerized hemoglobintrauma careemergency medicinecombat medicineveterinary medicinelyophilizationorgan preservationbovine hemoglobinbiotechnology incubator
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OxyVita Inc. Comparables
Compare OxyVita Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HbO2 Therapeutics | 91% | |
| VirTech Bio | 86% | |
| KaloCyte, Inc. | 84% | |
OxyVita Inc. Funding Rounds
Historical fundraising activity
OxyVita Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OxyVita Inc.'s valuation, stock price, and market status.
Firmographic Details
HeadquartersMiddletown, New York
Employee Range4
Year Founded2003
Last Funding—